Literature DB >> 30362287

Longitudinal changes in global cataract surgery rate inequality and associations with socioeconomic indices.

William Yan1,2, Wei Wang3, Peter van Wijngaarden1,4, Andreas Mueller1,2,4, Mingguang He1,2,4,3.   

Abstract

IMPORTANCE: Cataract is the leading cause of blindness and the second leading cause of vision impairment. The majority of people with vision impairment reside in low-resource settings with limited access to cataract surgery and services.
BACKGROUND: Cataract surgery rate (CSR) is a proxy measure for eye care service delivery and estimating the burden of cataract disease. This research aims to evaluate the longitudinal changes of CSR inequality globally and by income groups.
DESIGN: Systematic review. PARTICIPANTS: Studies published from January 2000 to December 2015 were considered for inclusion into the review.
METHODS: CSR data were retrieved from a systematic review of published literature (OVID Medline, Embase, PubMed, ISI, Web of Science), unpublished reports and data repositories. MAIN OUTCOME MEASURES: Inequality of CSR was measured on a global scale and between countries grouped by income levels using the Gini coefficient and concentration index, with respect to the human development index (HDI).
RESULTS: Overall, correlations between HDI and gross domestic product (GDP) per capita vs CSRs were observed with R2 values of 49.2% (β = 5.01, P < 0.001) and 38.9% (β = 0.56, P < 0.001), respectively. Analysis of longitudinal CSR data using generalized estimation equation models revealed strong associations between CSR and HDI (P < 0.001), GDP (P < 0.001) and the proportion of people aged ≥50 (P = 0.001). Overall, the trend of inequality in worldwide CSR remained relatively stable. CONCLUSIONS AND RELEVANCE: Inequalities in cataract service provision were found between countries grouped by income and associated with socioeconomic indicators.
© 2018 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  cataract surgery rate; health inequality; socioeconomic

Mesh:

Year:  2018        PMID: 30362287     DOI: 10.1111/ceo.13430

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  Efficacy, safety and visual outcomes of cataract surgeries performed during blindness prevention programs in different locations in Kenya.

Authors:  Jaime Javaloy; Tomás Moya; Gonzalo Muñoz; Cesar Albarrán-Diego; José Valls-Martínez; Raul Montalbán; Milagro Inés Murillo; Isabel Signes-Soler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-29       Impact factor: 3.117

2.  Long Noncoding RNA NEAT1 Regulates TGF-β2-Induced Epithelial-Mesenchymal Transition of Lens Epithelial Cells through the miR-34a/Snail1 and miR-204/Zeb1 Pathways.

Authors:  Ning Dong
Journal:  Biomed Res Int       Date:  2020-05-31       Impact factor: 3.411

3.  Are we advancing universal health coverage through cataract services? Protocol for a scoping review.

Authors:  Chan Ning Lee; Jacqueline Ramke; Ian McCormick; Justine H Zhang; Ada Aghaji; Nyawira Mwangi; Helen Burn; Iris Gordon; Mayinuer Yusufu; Mingguang He; Juan Carlos Silva; Matthew J Burton
Journal:  BMJ Open       Date:  2020-07-08       Impact factor: 2.692

4.  2',3'-Cyclic-nucleotide 3'-phosphodiesterase contributes to epithelial-mesenchymal transition of lens epithelial cells through the notch signalling pathway.

Authors:  Yue Li; Yu Zhao; Yan Wang
Journal:  Cell Prolif       Date:  2019-10-16       Impact factor: 6.831

5.  Acetyl-11-Keto-Beta Boswellic Acid (AKBA) Protects Lens Epithelial Cells Against H2O2-Induced Oxidative Injury and Attenuates Cataract Progression by Activating Keap1/Nrf2/HO-1 Signaling.

Authors:  Tianke Yang; Xiaolei Lin; Hongzhe Li; Xiyue Zhou; Fan Fan; Jianing Yang; Yi Luo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

6.  Toll-like receptor 3 gene regulates cataract-related mechanisms via the Jagged-1/Notch signaling pathway.

Authors:  Weiwei Xie; Qihua Yu; Layi Wang; Yongqing Shao; Qingyun Bo; Guohai Wu
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.